Novozymes A/S Company Profile (OTCMKTS:NVZMY)

About Novozymes A/S

Novozymes A/S logoNovozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions. The Food & Beverages (old Food & Beverages Enzymes) manufactures enzymes for the food industry. The Bioenergy (old Bioenergy Enzymes) provides enzymes to the energy industry. The Agriculture & Feed area combines old Feed & Other Technical Enzymes area (enzymes sales to the feed industry) and microorganism sales for aquaculture and agriculture. The Technical & Pharma area combines old Feed & Other Technical Enzymes area (enzymes to other technical industries), microorganism sales for wastewater treatment, and Biopharma (recombinant ingredients and technologies).

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: NVZMY
  • CUSIP:
Key Metrics:
  • Previous Close: $38.47
  • 50 Day Moving Average: $37.88
  • 200 Day Moving Average: $39.01
  • 52-Week Range: $31.57 - $49.55
  • Trailing P/E Ratio: 26.34
  • Foreward P/E Ratio: 23.62
  • P/E Growth: 23.88
  • Market Cap: $11.32B
  • Outstanding Shares: 297,618,000
  • Beta: 0.96
Profitability:
  • Net Margins: 21.57%
  • Return on Equity: 27.48%
  • Return on Assets: 16.97%
Debt:
  • Current Ratio: 1.79%
  • Quick Ratio: 1.10%
Additional Links:
Companies Related to Novozymes A/S:

Analyst Ratings

Consensus Ratings for Novozymes A/S (OTCMKTS:NVZMY) (?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Novozymes A/S (OTCMKTS:NVZMY)
Show:
DateFirmActionRatingPrice TargetDetails
2/10/2017J P Morgan Chase & CoDowngradeOverweight -> NeutralView Rating Details
1/5/2017Sanford C. BernsteinUpgradeMkt Perform -> OutperformView Rating Details
9/27/2016Berenberg BankInitiated CoverageSellView Rating Details
1/20/2016Goldman Sachs Group, Inc. (The)UpgradeSell -> NeutralView Rating Details
8/7/2015Nordea Equity ResearchDowngradeBuy -> HoldView Rating Details
4/16/2015DanskeDowngradeBuy -> HoldView Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for Novozymes A/S (OTCMKTS:NVZMY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/22/2015$0.36$0.36ViewN/AView Earnings Details
8/6/2015$0.35$0.33ViewN/AView Earnings Details
4/24/2015$0.33$0.33ViewN/AView Earnings Details
1/20/2015$0.23$0.30ViewN/AView Earnings Details
10/27/2014$0.35$0.34ViewN/AView Earnings Details
8/15/2014$0.38$0.34ViewN/AView Earnings Details
5/20/2014$0.33$0.40ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Novozymes A/S (OTCMKTS:NVZMY)
Current Year EPS Consensus Estimate: $1.49 EPS
Next Year EPS Consensus Estimate: $1.61 EPS

Dividends

Dividend History for Novozymes A/S (OTCMKTS:NVZMY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Novozymes A/S (OTCMKTS:NVZMY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Novozymes A/S (OTCMKTS:NVZMY)
DateHeadline
marketwatch.com logoAre microbes the next revolution coming to Big Ag? (OTCMKTS:NVZMY)
www.marketwatch.com - January 28 at 5:20 AM
capitalcube.com logoETFs with exposure to Novozymes A/S : January 24, 2017 (OTCMKTS:NVZMY)
www.capitalcube.com - January 24 at 7:42 PM
capitalcube.com logoNovozymes A/S :NVZMY-US: Earnings Analysis: Q4, 2016 By the Numbers : January 23, 2017 (OTCMKTS:NVZMY)
www.capitalcube.com - January 23 at 7:17 PM
finance.yahoo.com logo6:53 am Novozymes higher by 2% overseas following FY16 results (OTCMKTS:NVZMY)
finance.yahoo.com - January 18 at 9:00 AM
marketexclusive.com logoAnalyst Upgrades – Novozymes A/S – (NASDAQ:NVZMY) Stock Gets Upgraded By Sanford C. Bernstein from Market Perform to Outperform (OTCMKTS:NVZMY)
marketexclusive.com - January 6 at 7:39 PM
capitalcube.com logoETFs with exposure to Novozymes A/S : December 19, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - December 20 at 1:03 PM
us.rd.yahoo.com logoNovozymes upgraded by JP Morgan (OTCMKTS:NVZMY)
us.rd.yahoo.com - December 9 at 6:53 PM
marketrealist.com logoDid Portfolio Shuffling Help the Fidelity Advisor Europe Fund in YTD 2016? (OTCMKTS:NVZMY)
marketrealist.com - October 27 at 6:36 PM
capitalcube.com logoNovozymes A/S : Neutral price; Buy/ Sell depends on fundamentals (OTCMKTS:NVZMY)
www.capitalcube.com - October 27 at 6:36 PM
capitalcube.com logoETF’s with exposure to Novozymes A/S : October 24, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - October 24 at 6:16 PM
capitalcube.com logoETF’s with exposure to Novozymes A/S : September 30, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - September 30 at 11:46 AM
capitalcube.com logoETF’s with exposure to Novozymes A/S : August 29, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - August 29 at 6:20 PM
capitalcube.com logoNovozymes A/S :NVZMY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - August 12 at 6:41 PM
marketrealist.com logoHow Portfolio Shifts Are Affecting Fidelity’s Europe Fund (OTCMKTS:NVZMY)
marketrealist.com - August 5 at 9:40 AM
capitalcube.com logoETF’s with exposure to Novozymes A/S : June 30, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - June 30 at 12:25 PM
capitalcube.com logoNovozymes A/S :NVZMY-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - June 3 at 11:29 AM
finance.yahoo.com logoConsumer Staples Delivered Top-Notch Performance for VGEAX (OTCMKTS:NVZMY)
finance.yahoo.com - April 29 at 9:08 AM
capitalcube.com logoETF’s with exposure to Novozymes A/S : March 29, 2016 (OTCMKTS:NVZMY)
www.capitalcube.com - March 29 at 11:03 AM
capitalcube.com logoNovozymes A/S :NVZMY-US: Earnings Analysis: Q4, 2015 By the Numbers (OTCMKTS:NVZMY)
www.capitalcube.com - March 28 at 11:46 AM
finance.yahoo.com logoAn Above-Average Year for FHJUX (OTCMKTS:NVZMY)
finance.yahoo.com - March 21 at 12:29 PM
finance.yahoo.com logoThe Fidelity Advisor Europe Fund: An Above-Average Year (OTCMKTS:NVZMY)
finance.yahoo.com - February 22 at 7:03 PM
seekingalpha.com logoKerry Group Plc - The Biggest Fish In The Highly Fragmented Ingredient Market - Seeking Alpha (OTCMKTS:NVZMY)
seekingalpha.com - January 30 at 1:44 PM
finance.yahoo.com logoHow the Fidelity Advisor Europe Fund Allocated Its Portfolio in 2015 (OTCMKTS:NVZMY)
finance.yahoo.com - January 25 at 4:11 PM
capitalcube.com logoNovozymes A/S Earnings Analysis: Q4, 2015 By the Numbers (OTCMKTS:NVZMY)
www.capitalcube.com - January 21 at 12:22 PM
finance.yahoo.com logoNovozymes upgraded by Goldman (OTCMKTS:NVZMY)
finance.yahoo.com - January 20 at 8:22 AM
marketwatch.com logoNovozymes profit up; sees moderate growth in 2016 - MarketWatch (OTCMKTS:NVZMY)
www.marketwatch.com - January 19 at 12:34 PM
marketwatch.com logoNovozymes profit up; sees moderate growth in 2016 (OTCMKTS:NVZMY)
www.marketwatch.com - January 19 at 12:34 PM
News IconAnalysts Bullish on Novozymes A S - ADR (NVZMY) EPS - OctaFinance.com (OTCMKTS:NVZMY)
www.octafinance.com - January 18 at 7:43 PM
finance.yahoo.com logoA Look at FHJUX’s Portfolio through November 2015 (OTCMKTS:NVZMY)
finance.yahoo.com - December 23 at 5:00 PM
finance.yahoo.com logoThe Fidelity Advisor Europe Fund Class A (FHJUX): Historical Overview (OTCMKTS:NVZMY)
finance.yahoo.com - October 28 at 2:02 PM
capitalcube.com logoNovozymes A/S Earnings Q3, 2015 (OTCMKTS:NVZMY)
www.capitalcube.com - October 27 at 11:18 AM
capitalcube.com logoNovozymes A/S – Value Analysis (US OTC:NVZMY) : October 23, 2015 (OTCMKTS:NVZMY)
www.capitalcube.com - October 23 at 2:02 PM
finance.yahoo.com logoThere is uncertainty around biofuels: Novzymes CEO (OTCMKTS:NVZMY)
finance.yahoo.com - October 22 at 2:15 AM
capitalcube.com logoNovozymes A/S Q2 Earnings Analysis: By the Numbers, 2015 (OTCMKTS:NVZMY)
www.capitalcube.com - August 24 at 1:40 PM
finance.yahoo.com logoNovozyme earnings weaker than expected (OTCMKTS:NVZMY)
finance.yahoo.com - August 6 at 2:15 AM
thestreet.com logoEuropean Stocks Rise on Climb in German Investor Confidence (OTCMKTS:NVZMY)
www.thestreet.com - January 20 at 6:24 AM
sg.finance.yahoo.com logoScience on the job: Teachers learn from tech firms (OTCMKTS:NVZMY)
sg.finance.yahoo.com - July 26 at 10:36 AM

Social

What is Novozymes A/S's stock symbol?

Novozymes A/S trades on the OTCMKTS under the ticker symbol "NVZMY."

How do I buy Novozymes A/S stock?

Shares of Novozymes A/S can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Novozymes A/S stock cost?

One share of Novozymes A/S stock can currently be purchased for approximately $38.03.

Novozymes A/S (OTCMKTS:NVZMY) Chart for Friday, February, 24, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Novozymes A/S (OTCMKTS:NVZMY)

Earnings History Chart

Earnings by Quarter for Novozymes A/S (OTCMKTS:NVZMY)

Dividend History Chart

Dividend Payments by Quarter for Novozymes A/S (OTCMKTS:NVZMY)

Last Updated on 2/24/2017 by MarketBeat.com Staff